References

A coming-of-age story: adult neurogenesis or adolescent neurogenesis in rodents?

10.3389/fnins.2024.1383728 · 2024 · External reference

Laminin and integrin in LAMA2-related congenital muscular dystrophy: from disease to therapeutics

10.3389/fnmol.2020.00001 · 2020 · External reference

Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy

10.1093/hmg/ddaa104 · 2020 · External reference

Mechanisms of Myofibre death in muscular dystrophies: the emergence of the regulated forms of necrosis in myology

10.3390/ijms24010362 · 2022 · External reference

Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice

10.1093/hmg/ddq499 · 2011 · External reference

Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A

10.1093/hmg/ddr427 · 2011 · External reference

Muscular dystrophies

10.1016/j.ccm.2018.01.004 · 2018 · External reference

Improved muscle strength and mobility in the dy2J/dy2J mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate

10.1016/j.nmd.2010.02.002 · 2010 · External reference

The role of TGF-β1 during skeletal muscle regeneration

10.1002/cbin.10725 · 2017 · External reference

Unresolved reference

2022 · External reference

Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy/dy Mouse

10.1002/ana.22694 · 2012 · External reference

Muscle injury causes long-term changes in stem-cell DNA methylation

10.1073/pnas.2212306119 · 2022 · External reference

Transgenic overexpression of laminin α1 chain in laminin α2 chain–deficient mice rescues the disease throughout the lifespan

10.1002/mus.21616 · 2010 · External reference

A family of laminin α2 chain-deficient mouse mutants: advancing the research on LAMA2-CMD

10.3389/fnmol.2020.00059 · 2020 · External reference

Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice

10.1093/hmg/ddh190 · 2004 · External reference

Laminin α1 reduces muscular dystrophy in dy2J mice

10.1016/j.matbio.2018.02.024 · 2018 · External reference

Laminin-211 in skeletal muscle function

10.4161/cam.22618 · 2013 · External reference

Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism

10.1038/nm.4367 · 2019 · External reference

A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene

10.1038/s41586-019-1430-x · 2019 · External reference

Bortezomib partially improves laminin α2 chain–deficient muscular dystrophy

10.1016/j.ajpath.2014.01.019 · 2014 · External reference

Elevated satellite cell number in Duchenne muscular dystrophy

10.1007/s00441-010-0976-6 · 2010 · External reference

Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models

10.1172/jci3705 · 1998 · External reference

The jam session between muscle stem cells and the extracellular matrix in the tissue microenvironment

10.1038/s41536-022-00204-z · 2022 · External reference

Aberrant repair and fibrosis development in skeletal muscle

10.1186/2044-5040-1-21 · 2011 · External reference

Autophagy increase in merosin-deficient congenital muscular dystrophy type 1A

10.4081/ejtm.2023.11501 · 2023 · External reference

Loss of cell-autonomously secreted laminin-α2 drives muscle stem cell dysfunction in LAMA2-related muscular dystrophy

10.1038/s41467-025-65703-1 · 2025 · External reference

Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype

10.1172/jci90854 · 2017 · External reference

Muscular dystrophies

10.1016/s0140-6736(12)61897-2 · 2013 · External reference

Fibrosis inhibition and muscle histopathology improvement in laminin-α2-deficient mice

10.1002/mus.21706 · 2010 · External reference

Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice

10.1126/scitranslmed.aal4649 · 2017 · External reference

Muscle satellite cells and impaired late stage regeneration in different murine models for muscular dystrophies

10.1038/s41598-019-48156-7 · 2019 · External reference

Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy

10.1016/j.ajpath.2011.12.019 · 2012 · External reference

Developmental myosins: expression patterns and functional significance

10.1186/s13395-015-0046-6 · 2015 · External reference

Control of satellite cell function in muscle regeneration and its disruption in ageing

10.1038/s41580-021-00421-2 · 2022 · External reference

Identification of a novel mutant transcript of laminin oc2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice

10.1093/hmg/4.6.1055 · 1995 · External reference

Persistent NF-κB activation in muscle stem cells induces proliferation-independent telomere shortening

10.1016/j.celrep.2021.109098 · 2021 · External reference

The congenital muscular dystrophies

10.1002/cns3.20050 · 2024 · External reference

Identification of homozygous and heterozygous dy2J mice by PCR

10.1016/s0960-8966(99)00056-5 · 2000 · External reference

Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies

10.1146/annurev.physiol.010908.163216 · 2009 · External reference

Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene

10.1038/ng1194-297 · 1994 · External reference

Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies

10.1016/j.matbio.2017.11.009 · 2018 · External reference

Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways

10.1007/s00018-013-1330-4 · 2013 · External reference